Aptamer-Based Enforced Phosphatase-Recruiting Chimeras Inhibit Receptor Tyrosine Kinase Signal TransductionShanchao Wu, Weihong Tan, Aili Zhou et al.|Journal of the American Chemical Society|2024Cited by 18
A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung CancerShanchao Wu, Weihong Tan, Xinyi Zhou et al.|ACS Nano|2025Cited by 7
Targeted Covalent Nanodrugs Reinvigorate Antitumor Immunity and Kill Tumors via Improving Intratumoral Accumulation and Retention of DoxorubicinZhijia Zhu, Zilong Zhao, Yanlan Liu et al.|ACS Nano|2025Cited by 6